Search research articles
Contact Us
Filters
Showing results (21-30 of 292) with videos related to
Page
of 30
Sort By:
Orphanet Journal of Rare Diseases
|
June 21, 2011
Pricing and reimbursement of orphan drugs: the need for more transparency
Steven Simoens
Frontiers in Neurology
|
November 7, 2022
Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
Steven Simoens
Plos One
|
January 4, 2014
Assessment of methodological quality of economic evaluations in belgian drug reimbursement applications
Steven Simoens
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2010
Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy
Steven Simoens
Journal of Medical Economics
|
September 3, 2009
Health economics of market access for biopharmaceuticals and biosimilars
Steven Simoens
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 8, 2014
Health technologies for rare diseases: does conventional HTA still apply?
Steven Simoens
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Health Economics of Antibiotics
Steven Simoens
The Australian Journal of Rural Health
|
June 18, 2004
Experiences of Organization for Economic Cooperation and Development countries with recruiting and retaining physicians in rural areas
Steven Simoens
Pharmacy Practice
|
August 26, 2014
The Portuguese generic medicines market: a policy analysis
Steven Simoens
International Journal of Environmental Research and Public Health
|
January 6, 2010
Health economic assessment: a methodological primer
Steven Simoens
Page
of 30
Search research articles
Search
Showing results (21-30 of 292) with videos related to
Sort By:
Page
of 30
Orphanet Journal of Rare Diseases
|
June 21, 2011
Pricing and reimbursement of orphan drugs: the need for more transparency
Steven Simoens
Frontiers in Neurology
|
November 7, 2022
Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
Steven Simoens
Plos One
|
January 4, 2014
Assessment of methodological quality of economic evaluations in belgian drug reimbursement applications
Steven Simoens
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2010
Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy
Steven Simoens
Journal of Medical Economics
|
September 3, 2009
Health economics of market access for biopharmaceuticals and biosimilars
Steven Simoens
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 8, 2014
Health technologies for rare diseases: does conventional HTA still apply?
Steven Simoens
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Health Economics of Antibiotics
Steven Simoens
The Australian Journal of Rural Health
|
June 18, 2004
Experiences of Organization for Economic Cooperation and Development countries with recruiting and retaining physicians in rural areas
Steven Simoens
Pharmacy Practice
|
August 26, 2014
The Portuguese generic medicines market: a policy analysis
Steven Simoens
International Journal of Environmental Research and Public Health
|
January 6, 2010
Health economic assessment: a methodological primer
Steven Simoens
Page
of 30